Background Patients who sustain blunt liver trauma and are treated at an ACS-COT verified level 1 trauma center have an overall lower risk of mortality compared with patients admitted to a level 2 trauma center. However, elements contributing to these differences are unknown. We hypothesize that practice variation exists between trauma centers in management of blunt liver injury. Our objective is to identify practice variations and their effect on clinical outcomes. Methods Data from a statewide collaborative quality initiative for trauma was utilized. The dataset contains information from 29 ACS-COT verified level 1 and 2 trauma centers from 2011 to 2016. Propensity score matching was used to create cohorts of patients treated at level 1 or 2 trauma centers. The 1:1 matched cohorts were used to compare in-hospital mortality, management strategy, complications, ICU and hospital LOS, and failure to rescue. Results 454 patients with grade 3 or higher blunt liver injury were included. Patients treated at level 2 trauma centers had higher in-hospital mortality than those treated at level 1 trauma centers (15.4% vs. 8.8%, p=0.03). Level 2 trauma centers utilized angiography less compared with level 1 centers (p=0.007) and admitted significantly fewer patients to the ICU (p=0.002). ICU status was associated with reduced mortality (7.2% vs. 23.9%, p
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2zVCb7c
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Timing of Gestation After Laparoscopic Sleeve Gastrectomy (LSG): Does it Influence Obstetrical and Neonatal Outcomes of Pregnancies? Ivor Le...
-
Objectives: The Pediatric Acute Lung Injury Consensus Conference developed a pediatric specific definition for acute respiratory distress s...
-
Resuscitation is a System I Game... EMCrit by Scott Weingart . from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1Svu...
-
Hard to believe, but there was a time we were without the most necessary EMS tools. That all changed, thanks to these creative minds. fro...
-
Chemotherapy Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction Conclusions: The ability to improve symptoms and LVEF in u...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου